SIRION Biotech GmbH

General information

SIRION Biotech GmbH
Am Klopferspitz 19
82152 Martinsried, Bavaria
Germany

Contact person: Christian Thirion, CEO
Company main phone: +49 (89) 700961999
Website: https://www.sirion-biotech.com

Year founded:	2006
Source of foundation:	Independent foundation

Corporate description / mission:
SIRION Biotech GmbH is a service provider for preclinical target research. The company engages in the field of functional gene analysis and cell models for basic research, and drug and compound development; and provides technology in the area of viral vector systems. The company offers adenovirus and adeno-associated virus services for research, in vivo applications, and cell-based assays; customized cells for overexpression for target identification, pathway research, and life cell imaging; shRNA validation platform for identification of shRNAs for gene knockdown; cell line development services, such as clonal cell lines and cell immortalization; and customized gene knockdown cells for target identification and pathway research.

State of ownership: Private / independent
Headquarters: Yes

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Cell culture
CRO (Contract Research Organization)
Screening
Synthesis services

Primary therapeutic areas:

Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology

Business model:

Manufacturer
Out-licensing
Research on contract basis
Service company

Customer segments:

Large biotech & big pharma
Small biotech

Distribution:

Direct (own sales force)
Indirect (independent dealer)

Summary Products / Services / Technologies

Technology used:
RNAiONE™
BAC technology, etc.